45 Stocks Moving in Tuesday's Pre-Market Session

Loading...
Loading...

Gainers

  • Onconova Therapeutics, Inc. ONTX rose 51.4% to $0.439 in pre-market trading after climbing over 11% on Monday. Onconova Therapeutics, last week, filed investigational new drug application for multi-kinase CDK4/6 inhibitor ON 123300.
  • Corbus Pharmaceuticals Holdings, Inc. CRBP shares rose 47.5% to $1.80 in pre-market trading. Corbus Pharmaceuticals, last month, reported downbeat quarterly results.
  • Sundial Growers Inc. SNDL rose 33.8% to $0.975 in pre-market trading after jumping 96% on Monday. Sundial reported elimination of senior secured second lien convertible notes.
  • Jaguar Health, Inc. JAGX shares rose 31.6% to $ 0.46 in pre-market trading. Jaguar Health shares jumped over 66% on Monday after the company announced plans to develop and commercialize its Crofelemer.
  • Dunxin Financial Holdings Limited DXF rose 31.4% to $1.80 in pre-market trading after the company signed an Intentional Cooperation Agreement with Baite Biologic Group.
  • CF Finance Acquisition Corp. II CFII rose 20.2% to $12.00 in pre-market trading. View, the leader in Smart Windows, announced plans to merge with CF Finance Acquisition Corp. II.
  • NTN Buzztime, Inc. NTN rose 20.1% to $2.45 in pre-market trading. NTN Buzztime released quarterly results last month.
  • Pennsylvania Real Estate Investment Trust PEI rose 18.2% to $1.30 in pre-market trading after the company reported its prepackaged financial restructuring plan was confirmed by the court.
  • HEXO Corp. HEXO rose 17% to $1.31 in pre-market trading after jumping around 30% on Monday.
  • F-star Therapeutics, Inc. FSTX rose 16% to $8.16 in pre-market trading.
  • SPI Energy Co., Ltd. SPI rose 13.8% to $12.73 in pre-market trading. SPI Energy’s Phoenix Motorcars deployed two battery powered utility trucks to the Port of Oakland.
  • Li Auto Inc. LI rose 13.4% to $40.82 in pre-market trading after declining over 8% on Monday.
  • Genetic Technologies Limited GENE rose 13.3% to $3.59in pre-market trading after the company reported an agreement for distribution rights of Taliaz's Predictix products in Australia, New Zealand and US.
  • Moderna, Inc. MRNA rose 12.6% to $171.89 in pre-market trading after surging over 20% on Monday. Moderna filed for US FDA emergency use authorization for its COVID-19 vaccine, Reuters reported.
  • IDT Corporation IDT rose 12% to $13.35 in pre-market trading. IDT is expected to report Q1 earnings on December 3.
  • Advaxis, Inc. ADXS shares rose 11.9% to $0.33 in pre-market trading. Advaxis, last week, reported pricing of $8 million public offering.
  • Trident Acquisitions Corp. TDAC rose 11.4% to $13.59in pre-market trading.
  • Kopin Corporation KOPN rose 11% to $2.22 in pre-market trading after surging over 23% on Monday.
  • Gores Metropoulos, Inc. GMHI rose 10.8% to $20.40 in pre-market trading after jumping around 20% on Monday.
  • Altimmune, Inc. ALT rose 10.8% to $13.55 in pre-market trading after gaining around 16% on Monday. Altimmune, last week, announced submission of investigational new drug application for AdCOVID single-dose intranasal COVID-19 vaccine.
  • The ExOne Company XONE rose 10.7% to $13.21 in pre-market trading after declining 6% on Monday.
  • Arbutus Biopharma Corporation ABUS rose 10.4% to $5.00 in pre-market trading. Arbutus Biopharma last month said it will advance its AB-729 into a phase 2 study.
  • Peabody Energy Corporation BTU rose 10.4% to $1.49 in pre-market trading after declining over 16% on Monday.
  • XPeng Inc. XPEV shares rose 9.4% to $64.14 in pre-market trading as the company reported a strong year-over-year and month-over-month rise in deliveries for November. Xpeng said deliveries rose 342% year-over-year to 4,224 vehicles in November.
  • China Automotive Systems, Inc. CAAS rose 7.2% to $11.25 in pre-market trading. China Automotive Systems shares jumped 174% on Monday after the company announced a significant increase in sales to Chinese electric vehicle companies.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Titan Pharmaceuticals, Inc. TTNP fell 21.6% to $4.00 in pre-market trading.
  • Medigus Ltd. MDGS shares fell 16.1% to $2.45 in pre-market trading. Medigus’ subsidiary Eventer Technologies, signed a commercial licensing agreement with the virtual entertainment and event technology company, Screenz Cross Media Ltd.
  • ECMOHO Limited MOHO fell 14% to $2.29 in pre-market trading after the company swung to a loss in the third quarter.
  • Adial Pharmaceuticals, Inc. ADIL fell 11.2% to $2.07 in pre-market trading after climbing around 20% on Monday.
  • CTI BioPharma Corp. CTIC fell 10.8% to $3.21 in pre-market trading. CTI BioPharma yesterday announced publication of article highlighting pacritinib data from PAC203 Phase 2 study in myelofibrosis in blood advances.
  • Apollo Endosurgery, Inc. APEN shares fell 10.6% to $4.30 in pre-market trading. Apollo Endosurgery shares jumped around 77% on Monday after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $2 to $5 per share.
  • QuantumScape Corporation QS fell 9.6% to $42.50 in pre-market trading. QuantumScape shares jumped 27% on Monday after Bernstein initiated coverage on the stock with an Underperform rating and announced a price target of $28.
  • Cleveland-Cliffs Inc. CLF shares fell 9.2% to $10.00 in pre-market trading. KeyBanc maintained Cleveland-Cliffs with an Overweight and raised the price target from $12 to $14.
  • Ferroglobe PLC GSM fell 8.7% to $1.16 in pre-market trading after declining 8% on Monday. Ferroglobe released quarterly earnings last week.
  • Sunesis Pharmaceuticals, Inc. SNSS shares fell 8.6% to $1.70 in pre-market trading. Sunesis Pharmaceuticals shares jumped 24% on Monday after the company announced a merger with Viracta.
  • Alterity Therapeutics Limited ATHE fell 7.8% to $1.40 in pre-market trading. Alterity Therapeutics, last month, said its patent for neurodegenerative diseases was approved.
  • Iterum Therapeutics plc ITRM fell 7.7% to $0.6750 in pre-market trading. Iterum Therapeutics recently submitted New Drug Application to the FDA for oral sulopenem.
  • Yunji Inc.. YJ shares fell 7.3% to $3.03 in pre-market trading. Yunji shares fell 14% on Monday after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and announced a $3.4 price target.
  • SuperCom Ltd. SPCB fell 6.6% to $1.13 in pre-market trading. SuperCom shares jumped over 45% on Monday after the company won a contract to provide its PureSecurity Electric Monitoring suite in Wisconsin.
  • Sunnova Energy International Inc. NOVA fell 5.6% to $38.25 in pre-market trading after the company announced the launch of a primary and secondary offering of 7 million shares of common stock.
  • Creative Realities, Inc. CREX fell 5.6% to $1.17 in pre-market trading after climbing over 20% on Monday.
  • Verastem, Inc. VSTM fell 5.5% to $1.90 in pre-market trading. Verastem Oncology yesterday initiated Phase 2 registration-directed trial of VS-6766 and Defactinib in recurrent low-grade serous ovarian cancer.
  • Zoom Video Communications, Inc. ZM fell 5.3% to $453.00 in pre-market trading. Zoom reported better-than-expected earnings and sales for its third quarter and issued upbeat guidance for the current quarter. However, the company’s gross margin shrank in the quarter..
  • Shift4 Payments Inc FOUR shares fell 5.3% to $58.38 in pre-market trading after the company announced a secondary offering of 8 million shares of Class A common stock.
  • SCWorx Corp. WORX fell 5.2% to $1.99 in pre-market trading after dropping over 5% on Monday.
Loading...
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPre-Market MoversTop Gainers
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...